PHARMAC documents that matched your search:
Two changes to the dispensing frequency of medicines
(2 pages, 419 KB)
AstraZeneca proposal Betaloc CR, Bricanyl, Pulmicort and Oxis 6 mg
(2 pages, 424 KB)
Restricting the number of Plendil ER 2.5 mg tablets
(1 page, 194 KB)
The Schedule Analyst is responsible for ensuring the accurate and timely production and publication of the Pharmaceutical Schedule, which lists products for which government subsidy is payable. The Pharmaceutical Schedule is produced three times per year. The Schedule Analyst is also responsible for producing monthly Updates to the Pharmaceutical Schedule and managing associated issues.
Agreement offers relief for children with arthritis
(1 page, 36 KB)
Children with arthritis will have access to a new fully-subsidised treatment from 1 February 2004. That’s when PHARMAC will begin subsidising etanercept (Enbrel), a diseasemodifying agent for the treatment of rheumatoid arthritis.
Supply of pharmaceuticals to DHB hospitals and/or community pharmacies
(105 pages, 1194 KB)
A new treatment for depression will be funded from 1 January 2004 following an agreement between PHARMAC and pharmaceutical company Wyeth (NZ) Ltd.
Proposal to amend Special Authority criteria for alendronate
(1 page, 222 KB)